Evidence mapPaperPMID 39452893Full record

ReviewDiabetes care2024

Consensus Considerations and Good Practice Points for Use of Continuous Glucose Monitoring Systems in Hospital Settings.

Julie L V Shaw, Raveendhara R Bannuru, Lori Beach, Nuha A ElSayed, Guido Freckmann, Anna K Füzéry, Angela W S Fung, Jeremy Gilbert, Yun Huang, Nichole Korpi-Steiner and 13 more

Abstract readReviewConsensus Statement
In one paragraph

Review in Diabetes care, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. [Hospital diabetes management (Update 2026)].Wiener klinische Wochenschrift · 2026
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Artificial pancreas: the past and the future.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2025
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Association of Hypoglycemia With the Time to Dextrose in Treatment of Diabetes-Related Ketoacidosis.Clinical diabetes : a publication of the American Diabetes Association · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Julie L V ShawDivision of Biochemistry, Eastern Ontario Regional Laboratory Association and The Ottawa Hospital, and Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Ontario, Canada.ORCID 0000-0003-3983-8487
Raveendhara R BannuruAmerican Diabetes Association, Arlington, VA.ORCID 0000-0002-8069-5783
Lori BeachDivision of Biochemistry, IWK Health, Department of Pathology and Laboratory Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
Nuha A ElSayedAmerican Diabetes Association, Arlington, VA.
Guido FreckmannInstitut für Diabetes-Technologie, Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Ulm, Germany.
Anna K FüzéryAlberta Precision Laboratories, Edmonton, Alberta, Canada.
Angela W S FungDepartment of Pathology and Laboratory Medicine, St. Paul's Hospital, Providence Health Care and University of British Columbia, Vancouver, British Columbia, Canada.
Jeremy GilbertDivision of Endocrinology and Metabolism, Sunnybrook Health Sciences Centre, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Yun HuangDivision of Biochemistry, Kingston Health Sciences Centre, and Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada.
Nichole Korpi-SteinerDepartment of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC.
Samantha LoganAlberta Precision Laboratories, Edmonton, Alberta, Canada.
Rebecca LongoLahey Hospital & Medical Center, Burlington, MA.
Dylan MacKayDepartments of Food and Human Nutritional Sciences and Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
Lisa MaksProvidence Health Care, Vancouver, British Columbia, Canada.
Stefan PleusInstitut für Diabetes-Technologie, Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Ulm, Germany.
Kendall RogersDivision of Hospital Medicine, Department of Internal Medicine, The University of New Mexico School of Medicine, Albuquerque, NM.
Jane Jeffrie SeleyDivision of Endocrinology, Diabetes and Metabolism, Weill Cornell Medicine, New York, NY.
Zachary TaxinBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
Fiona Thompson-HutchisonIntegrated Community Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Nicole V TolanDepartment of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Nam K TranDepartment of Pathology and Laboratory Medicine, UC Davis Health, University of California, Davis, Sacramento, CA.
Guillermo E UmpierrezDivision of Endocrinology and Metabolism, Department of Medicine, Emory School of Medicine, Emory University, Atlanta, GA.ORCID 0000-0002-3252-5026
Allison A VennerAlberta Precision Laboratories, Edmonton, Alberta, Canada.

Funding

Technologies Advancing Translation - Regional CoreP30DK111024 · EMORY UNIVERSITY · 2025 to 2025
$775k
American Diabetes AssociationAssociation for Diagnostics and Laboratory MedicineCanadian Society of Clinical ChemistsDiabetes CanadaNIDDK NIH HHS P30 DK111024
6 · The paper itself

Abstract

Continuous glucose monitoring (CGM) systems provide frequent glucose measurements in interstitial fluid and have been used widely in ambulatory settings for diabetes management. During the coronavirus disease 2019 (COVID-19) pandemic, regulators in the U.S. and Canada temporarily allowed for CGM systems to be used in hospitals with the aim of reducing health care professional COVID-19 exposure and limiting use of personal protective equipment. As such, studies on hospital CGM system use have been possible. With improved sensor accuracy, there is increased interest in CGM usage for diabetes management in hospitals. Laboratorians and health care professionals must determine how to integrate CGM usage into practice. The aim of this consensus guidance document is to provide an update on the application of CGM systems in hospital, with insights and opinions from laboratory medicine, endocrinology, and nursing.

Indexed as

Blood GlucoseContinuous Glucose MonitoringDiabetes MellitusBlood Glucose Self-MonitoringCOVID-19HospitalsHumansPandemicsPneumonia, ViralSARS-CoV-2Blood Glucose

Identifiers

PMID39452893
PMCPMC12328255

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.